VITALITY
Report
- Report Number
- 2124215-2012-12574
- Event Type
- Malfunction
- Date Received
- October 10, 2012
- Date of Event
- July 6, 2011
- Report Date
- September 17, 2012
- Manufacturer
- GUIDANT CRM CLONMEL IRELAND
- Product Code
- LWS
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A REVIEW OF DEVICE MEMORY REVEALED THAT THE DEVICE DECLARED ELECTIVE REPLACEMENT INDICATOR (ERI) AFTER EXPERIENCING TWO CONSECUTIVE CHARGE TIMES GREATER THAN THE EXTENDED MID-LIFE ERI CHARGE TIME LIMIT. THE OBSERVED RATE OF BATTERY USAGE WAS COMPARED TO THE EXPECTED RATE OF BATTERY USAGE; THE RESULTS INDICATED THAT THE MONITORING VOLTAGE WAS NORMAL. ALTHOUGH THE BATTERY ITSELF HAD NOT DEPLETED PREMATURELY, ERI WAS TRIGGERED EARLIER THAN EXPECTED BY EXTENDED CHARGE TIMES DUE TO A HIGHER-THAN-TYPICAL BUILDUP OF INTERNAL BATTERY IMPEDANCE.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT WHILE THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) WAS IMPLANTED, IT SHOWED AN EXTENDED CHARGE TIME. THERE WAS NO ALLEGATION OF PREMATURE BATTERY DEPLETION. BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) WAS CONTACTED FOR A LONGEVITY ESTIMATE AND TS RECOMMENDED TO FOLLOW THE RECOMMENDATIONS PROVIDED IN DEVICE LABELING FOR FOLLOW-UPS. NO ADVERSE PATIENT EFFECTS WERE REPORTED. OVER A YEAR LATER, THIS ICD WAS RETURNED FOR DISPOSAL ONLY, WITH NO REPORTED PRODUCT PERFORMANCE ISSUES AND NO REPORTED ADVERSE PATIENT EFFECTS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | VITALITY | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | LWS | GUIDANT CRM CLONMEL IRELAND | T135 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 88 YR | T135| 0185 |